Should be avoided in people with a carnitine transport disorder, such as primary systemic carnitine deficiency, as it may exacerbate the condition
When you compare the weight loss doses, semaglutide at 2.4 mg causes significantly more nausea than tirzepatide at any dose, despite tirzepatide producing greater weight loss
If a compounded formula includes additives (for example, B12) or uses a salt form, ask why, and confirm the documentation supports your individualized need
Our role is to distribute the products, we do not offer a nutritional or product advice service
Most patients begin noticing abdominal changes around the 2-week mark, particularly a shift in how the midsection feels
One leads to dangerous dosing changes